Skip navigation
Real-Time Quotes
Get Free Real-Time Quotes Direct From the NYSE and the NASDAQ!
Company: Genentech, Inc.
Genentech, Inc. : [DNA  Loading...      ()   ]
Roche sued over its offer for Genentech, with CNBC's Mike Huckman
Drugmaker Roche offers to acquire all outstanding Genentech shares, with Franz Humer, Roche chairman
An outlook on the biotech sector, with Mad Money host Jim Cramer.
The Fast Money guys take a look at today's top business stories.
A look at whether the sector should be apart of your portfolio, with Catherine Arnold, Credit Suisse and Damien Conover, Morningstar
Roche will have to up its offer price in order to buy Genentech, but it's tough to speculate on what the right price is, Christophe Eggmann ...
Swiss drug giant Roche makes a play for all of Genentech and a look at earnings for the pharma sector, with CNBC's Mike Huckman
Roche offers to buy the rest of Genentech for $43.7B, reports CNBC's David Faber
Roche's offer to buy out Genentech appears to be a good deal, financially and pharmaceutically, according to Dr. Keither Schlagbauer from Fr...
Genentech shareholders probably won't be too happy with the bid price from Roche and there might be higher offers to come, Birgit Kulhoff fr...
Swiss drugmaker Roche Holding offered to buy all the outstanding shares in its US partner Genentech Monday. Peter McDougall, CEO of Druganal...
Roche offered to buy all outstanding shares in Genentech for $43.7 billion Monday. Franz B. Humer, chairman of Roche, discusses the deal.
Preparing your portfolio for next week, with Steve Grasso, Stuart Frankel and John O'Donoghue, Cowen & Co.
Peter Stock, president & CIO of Stock Investment Management Inc
In search of a bear market band-aid, with Kris Jenner, T. Rowe Price Health Sciences Fund portfolio manager and the Fast Money traders.
A look at the pharmaceutical company's earnings and performance of its cancer drug, with CNBC's Mike Huckman
A look at the biotech company's Q2 results, with Christopher Raymond, Robert W. Baird & Co. senior biotech analyst
The Fast Money guys take a look at today's top business stories.
Analysis of Genentech's Q2 results, with CNBC's Mike Huckman
Cramer believes the way to make money in this market is with healthcare stocks. He has recommended five this week: Genentech, Smith and Neph...
1 2 
Posts |  COMPANY : Genentech, Inc.
21 Jul 2008
Cramer ventures a guess as to who's next on the takeover list.... Read More
21 Jul 2008
With so much news Monday we need two "Word on the Street" posts... Read More
21 Jul 2008
You have to wonder at markets and analysts for that matter... Read More
21 Jul 2008
Bank of America made it four in a row with big banks beating expectations, and beating big: $0.72 is 40 percent higher than the $0.53 expected... Read More
15 Jul 2008
You’ve gotta’ love modern medicine... Read More
News |  COMPANY : Genentech, Inc.
Source: The Associated Press
Source: Reuters
Source: Reuters
Source: The Associated Press
Source: Reuters
Source: Reuters
Wednesday, 23 Jul 2008
Source: The Associated Press
Tuesday, 22 Jul 2008
Source: The Associated Press
Tuesday, 22 Jul 2008
Source: The Associated Press
Tuesday, 22 Jul 2008
Source: The Associated Press


Current DateTime: 05:24:02 24 Jul 2008
LinksList Documentid: 23188555



Current DateTime: 05:24:53 24 Jul 2008
LinksList Documentid: 23188557
HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis